Cara Therapeutics | CARA - EPS Earnings Per Share


Cara Therapeutics reported $-0.59 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.





Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Assertio Holdings USD -0.03 0.01 Sep/2024
Cara Therapeutics USD -0.59 4.45 Sep/2025
Cassava Sciences USD -0.26 0.04 Dec/2025
Chugai Pharma JPY 70.13 7.9 Mar/2026
Cipla INR 6.86 8.34 Mar/2026
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.23 0.82 Mar/2026
CSL USD 5.07 3 Dec/2025
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Pacira USD 0.6 0.54 Mar/2026
Pfizer USD 0.75 0.09 Mar/2026
RedHill Biopharma USD -1.31 33.38 Jun/2024
Supernus Pharmaceuticals USD 0.6 0.67 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024